Structured evidence table for Beta Alanine Fatigue Randomized Trial, generated from 3 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Beta Alanine Fatigue Randomized Trial | Methodological quality was assessed using the Cochrane RoB 2.0 tool, and the certainty of evidence was evaluated via the GRADE framework. | 1 | Liang W (2026) | No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. |
| Beta Alanine Fatigue Randomized Trial | Conclusion In conclusion, chronic β-alanine supplementation does not provide a clear improvement in total work capacity, maximal anaerobic power, or fatigue resistance during repeated sprinting. | 1 | Liang W (2026) | No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. |
| Beta Alanine Fatigue Randomized Trial | Objective Chronic beta-alanine supplementation is a prevalent nutritional strategy to augment intracellular buffering capacity via elevated muscle carnosine. | 1 | Liang W (2026) | No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. |
| Beta Alanine Fatigue Randomized Trial | While its ergogenic efficacy in continuous, high-intensity exercise is established, its impact on repeated sprint ability (RSA)-governed by extremely brief work bouts and phosphocreatine (PCr) kinetics-remains equivocal. | 1 | Liang W (2026) | No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. |
| Beta Alanine Fatigue Randomized Trial | Similarly, no between-roup differences were found for height (= 0.21, = 0.839, = 0.07,rivial effect), BMI (= −0.97, = 0.340, = −0.35, small effec), or body fat percentae (= −1.20, = 0.242, = −0.44, small effec). | 2 | Küçük Furkan Hasan (2026) | Effects of β-alanine supplementation on kickboxing-specific anaerobic performance, neuromuscular power, and strength endurance: A randomized, double-blind, placebo-controlled trial |
| Beta Alanine Fatigue Randomized Trial | Table 3 (26) (26) (26) (26) As shown in, no significant between-group differences were found in baseline physical performance variables (all p > 0.05). | 2 | Küçük Furkan Hasan (2026) | Effects of β-alanine supplementation on kickboxing-specific anaerobic performance, neuromuscular power, and strength endurance: A randomized, double-blind, placebo-controlled trial |
| Beta Alanine Fatigue Randomized Trial | The findings revealed meaningful group × time interaction effects, particularly for KASTtotal, where the β-alanine group improved from 40.36 ± 2.34 s at baseline to 38.85 ± 2.46 s after supplementation, while the control group showed only a minimal change (42.09 ± 3.18 s to 41.50 ± 3.63 s). | 2 | Küçük Furkan Hasan (2026) | Effects of β-alanine supplementation on kickboxing-specific anaerobic performance, neuromuscular power, and strength endurance: A randomized, double-blind, placebo-controlled trial |
| Beta Alanine Fatigue Randomized Trial | 1 2 3 4 1 β-Alanine is a non-essential amino acid that is naturally present in our daily diet and can also be synthesized by our body in the liver through the catabolism of pyrimidine nucleotides. | 2 | Küçük Furkan Hasan (2026) | Effects of β-alanine supplementation on kickboxing-specific anaerobic performance, neuromuscular power, and strength endurance: A randomized, double-blind, placebo-controlled trial |
| Beta Alanine Fatigue Randomized Trial | Although a significant decrease in beta human chorionic gonadotropin level was found in each of the two groups over time ( P P > 0.05). | 2 | Mardanian F (2025) | Evaluation of Letrozole and Methotrexate in the Management of Ectopic Pregnancy - A Randomized Clinical Trial Study. |
| Beta Alanine Fatigue Randomized Trial | Conclusion According to the results of this study, the biochemical and hematological parameters and success treatment rate did not differ significantly between the administration of letrozole and methotrexate. | 2 | Mardanian F (2025) | Evaluation of Letrozole and Methotrexate in the Management of Ectopic Pregnancy - A Randomized Clinical Trial Study. |
| Beta Alanine Fatigue Randomized Trial | Background Ectopic pregnancy (EP) is one of the critical health conditions worldwide. | 2 | Mardanian F (2025) | Evaluation of Letrozole and Methotrexate in the Management of Ectopic Pregnancy - A Randomized Clinical Trial Study. |
| Beta Alanine Fatigue Randomized Trial | Letrozole, an aromatase inhibitor that suppresses peripheral conversion of androgens to estrogens, has recently been introduced as a low-cost and minimal side effects treatment for EP. | 2 | Mardanian F (2025) | Evaluation of Letrozole and Methotrexate in the Management of Ectopic Pregnancy - A Randomized Clinical Trial Study. |
Source documents